Exploratory Study of Selected Stakeholder Insights Into Continuous Glucose Monitoring in T2D With Risk-Sharing Agreements

The article highlights how expanding access to continuous glucose monitoring (CGM) within risk-sharing agreements can improve glycemic outcomes and support value-based diabetes care, particularly for patients with poorly controlled type 2 diabetes. Real-world data from Ohio demonstrated rapid HbA1c reductions and high HEDIS target attainment when CGM was paired with reduced prior authorization and interdisciplinary care. An expert payer-provider panel recommended focusing risk-based CGM programs on non–insulin-treated patients with HbA1c >8%, using HbA1c and emerging CGM-derived metrics for performance measurement, and leveraging team-based models to reduce utilization and address health equity.